buyWeak
James Brian Windsor bought $898 of RNTX
President and CEO at AILERON THERAPEUTICS INC. 400 shares at an average of $2.24, traded Dec 5, 2024, filed Dec 9, 2024.
Conviction score
33Value
$898
400 shares
Holdings after
161
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- 0Trade size$898 at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-134522, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 5, 2024 | POpen-market purchase Common Stockindirect: By son | +239 | $2.24 | $535 | 239 | Dec 9, 2024 |
| Dec 5, 2024 | POpen-market purchase Common Stockindirect: By son | +161 | $2.25 | $362 | 161 | Dec 9, 2024 |
Related signals
Other insiders at AILERON THERAPEUTICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | RNTXbuy AILERON THERAPEUTICS INC | Josef H Von Rickenbach director | $50k 47,060 shares | +305% | |
| 38Weak | RNTXbuy AILERON THERAPEUTICS INC | James Brian Windsor See Remarks | $25k 25,000 shares | +1222% | |
| 26Weak | RNTXbuy AILERON THERAPEUTICS INC | Voss Capital, LP owner | $128k 104,183 shares | +13% | |
| 29Weak | RNTXbuy AILERON THERAPEUTICS INC | Voss Capital, LP owner | $423k 306,050 shares | +44% | |
| 37Weak | RNTXbuy AILERON THERAPEUTICS INC | James Brian Windsor President and COO | $758 225 shares | - | |
| 38Weak | RNTXbuy AILERON THERAPEUTICS INC | James Brian Windsor President and COO | $9,987 5,076 shares | first purchase |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.